Evidence map›Paper›PMID 40919292›Full record

ArticleOrganometallics2024

Bidentate Phosphine Ligand Impacts on Previously Inaccessible 5-Membered N-Heteroaryne Formation and Functionalization.

Erin E Plasek, Roman G Belli, Douglas M Kavaguti, Courtney C Roberts

Abstract read
In one paragraph

Article in Organometallics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Transition Metal-Free Heteroarene Insertion Into C─C Bonds of Benzocyclobutenones.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erin E PlasekUniversity of Minnesota, Minneapolis, MN 55455 USA.
Roman G BelliUniversity of Minnesota, Minneapolis, MN 55455 USA.
Douglas M KavagutiUniversity of Minnesota, Minneapolis, MN 55455 USA.
Courtney C RobertsUniversity of Minnesota, Minneapolis, MN 55455 USA.

Funding

Methods for Selective Functionalization of (Hetero)arene RingsR35GM146957 · NIGMS · UNIVERSITY OF MINNESOTA · PI Courtney C Roberts · 2022 to 2026
$1.9M
Upgrade of a 500 MHz NMR Spectrometer for Applications in Biomedical ResearchS10OD011952 · OD · UNIVERSITY OF MINNESOTA · PI HOYE, THOMAS R. · 2012 to 2012
$378k
NIGMS NIH HHS R35 GM146957NIH HHS S10 OD011952
6 · The paper itself

Abstract

5-Membered N-heteroarynes have long been considered synthetically inaccessible; however, we recently reported the use of a bisphosphine-ligated nickel center to stabilize and enable the formation of these otherwise unobtainable intermediates. Motivated by this success, we were compelled to study the role of the ancillary phosphine in aryne formation and reactivity. Herein, a set of four bidentate phosphine ligands with altered phosphine substituents and backbone length are interrogated for their competence as ancillary ligands for 5-membered N-heteroaryne formation. We determined that ligands with phenyl phosphine substituents or linker lengths longer than three carbons were unsuitable for this purpose, while ligands having alkyl phosphine substituents and one, two, or three carbon linkers allowed for successful aryne formation. Reactivity studies using 2-PyZnBr as a nucleophilic coupling partner revealed intriguing regioselectivity enhancement (up to >20:1 r.r.) when utilizing ligands with altered linker lengths. We hypothesize that regioselectivity can be traced back to structural differences between these Ni-aryne complexes, as evidenced by crystallographic characterization.

Indexed as

Arynesbidentate phosphinesN-heterocycles

Identifiers

PMID40919292
PMCPMC12410832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.